Clinical Trial Update: Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device [NA]

View source ↗

Summary

A clinical trial comparing 22G and 20G EUS Procore Fine Needle Biopsy devices for pancreatic neoplasms; the study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• EUS Procore Fine Needle Biopsy Device 20G
• EUS Procore Fine Needle Biopsy Device 22G

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Pancreas Neoplasms | NA | Status: UNKNOWN